Evidence map›Paper›PMID 34202367›Full record

ArticleMolecules (Basel, Switzerland)2021

Development, Characterization, and Immunomodulatory Evaluation of Carvacrol-loaded Nanoemulsion.

Amanda Gabrielle Barros Dantas, Rafael Limongi de Souza, Anderson Rodrigues de Almeida, Francisco Humberto Xavier Júnior, Maira Galdino da Rocha Pitta, Moacyr Jesus Barreto de Melo Rêgo, Elquio Eleamen Oliveira

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Antifungal activity against Candida albicans of methyl 3,5-dinitrobenzoate loaded nanoemulsion.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  8. Article
  9. Article
  10. Pharmaceutics · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Amanda Gabrielle Barros DantasLaboratory of Synthesis and Drug Delivery, State University of Paraiba, João Pessoa, PB 58071-160, Brazil.
Rafael Limongi de SouzaLaboratory of Synthesis and Drug Delivery, State University of Paraiba, João Pessoa, PB 58071-160, Brazil.
Anderson Rodrigues de AlmeidaLaboratory of Immunomodulation and Novel Therapeutic Approaches, Federal University of Pernambuco, Recife, PE 50670-901, Brazil.
Francisco Humberto Xavier JúniorDepartment of Pharmacy, Federal University of Paraíba, João Pessoa, PB 58051-900, Brazil.ORCID 0000-0001-8238-3380
Maira Galdino da Rocha PittaLaboratory of Immunomodulation and Novel Therapeutic Approaches, Federal University of Pernambuco, Recife, PE 50670-901, Brazil.
Moacyr Jesus Barreto de Melo RêgoLaboratory of Immunomodulation and Novel Therapeutic Approaches, Federal University of Pernambuco, Recife, PE 50670-901, Brazil.ORCID 0000-0002-1883-6012
Elquio Eleamen OliveiraLaboratory of Synthesis and Drug Delivery, State University of Paraiba, João Pessoa, PB 58071-160, Brazil.
Universidade Estadual da Paraíba · BRUniversidade Federal de Pernambuco · BRUniversidade Federal da Paraíba · BR

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88882440851/2019-01Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88882449935/2019-01State University of Paraíba 001/2021
6 · The paper itself

Abstract

Carvacrol (CV) is an essential oil with numerous therapeutic properties, including immunomodulatory activity. However, this effect has not been studied in nanoemulsion systems. The objective of this study was to develop an innovative carvacrol-loaded nanoemulsion (CVNE) for immunomodulatory action. The developed CVNE comprised of 5%

Indexed as

CymenesImmunologic FactorsCytokinesDrug Evaluation, PreclinicalEmulsionsHumansLeukocytes, MononuclearNanoparticlesPolysorbatescarvacrolCymenesCytokinesEmulsionsImmunologic FactorsPolysorbatescarvacrolcytokineimmunoregulationnanoemulsion

Identifiers

PMID34202367
PMCPMC8271444
OpenAlexW3173175850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.